MENU
PDSB
AS OF
Nov 19 closing price
Price
$0.75
Change
-$0.04 (-5.06%)
Capitalization
41.04M
126 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
PDSB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

PDS Biotechnology (PDSB) Earnings Date & Reports

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States... Show more

A.I. Advisor
published Earnings

PDSB is expected to report earnings to rise 8.79% to -20 cents per share on March 26

PDS Biotechnology PDSB Stock Earnings Reports
Q4'25
Est.
$-0.21
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.11
Q4'24
Beat
by $0.10
The last earnings report on November 13 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 503.81K shares outstanding, the current market capitalization sits at 41.04M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PDSB
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PDSB showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for PDSB
A.I. Advisor
published General Information

General Information

a developer of clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
303A College Road
Phone
+1 800 208-3343
Employees
25
Web
https://www.pdsbiotech.com